Metoprolol tartrate and Feldene drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metoprolol tartrate and Feldene. Common interactions include hypokalaemia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people who take Metoprolol tartrate and Feldene have. It is created by eHealthMe based on reports of 30 people who take Metoprolol tartrate and Feldene from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 24, 2023

30 people who take Metoprolol tartrate and Feldene together, and have interactions are studied.

What is Metoprolol tartrate?

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 81,372 Metoprolol tartrate users for its effectiveness, alternative drugs and more.

What is Feldene?

Feldene has active ingredients of piroxicam. It is often used in arthritis. eHealthMe is studying from 3,845 Feldene users for its effectiveness, alternative drugs and more.

Number of Metoprolol tartrate and Feldene reports submitted per year:

Common Metoprolol Tartrate and Feldene drug interactions by gender *:

female:

Hypokalaemia
Injury
Activities of daily living impaired
Basal cell carcinoma
Bone lesion
Bone pain
Bursitis
Cardiac disorder
Cellulitis
Cerebral atrophy

male:

Anhedonia
Anxiety
Back pain
Blood immunoglobulin g increased
Bone disorder
Bone pain
Cardiac arrest
Cardiac asthma
Cardiac failure congestive
Cardiomegaly

Common Metoprolol Tartrate and Feldene drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Somnolence
Suicidal ideation
Depression
Depression suicidal
Diarrhoea
Fatigue
Hypersomnia
Hypophagia
Migraine

50-59:

Chills
Drug ineffective
Infusion related reaction
Nephrolithiasis
Rheumatoid arthritis
Bronchitis

60+:

Anaemia
Anhedonia
Osteonecrosis of jaw
Angina unstable
Cardiac failure congestive
Dyspnoea exertional
General physical health deterioration
Haematochezia
Intervertebral disc degeneration
Oedema peripheral

Common conditions people have *:

Pain: 9 people, 30.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 26.67%
High Blood Cholesterol: 7 people, 23.33%
Cardiac Disorder: 6 people, 20.00%
Depression: 6 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.00%
Stable Angina (a constant chest pain): 5 people, 16.67%
Arrhythmias (irregular heartbeat): 5 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 5 people, 16.67%
Diabetes: 4 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Metoprolol tartrate and Feldene?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Kola E, Bakalli I, Celaj E, Lluka R, Heta S, Sallabanda S, "Stomach perforation from piroxicam poisoning", Paediatrics Today, 2012 Jun .